首页> 外文OA文献 >>Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature Corrigendum

【2h】

>Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature Corrigendum

机译：>抗CD22和抗CD19嵌合抗原受体T细胞的抗CD22和抗CD19嵌合抗原受体T细胞用于儿科pH样B-所有患者在卡特 - 细胞和HAPLO-HSCT疗法后复发的患者：文献报告和审查逆势

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jingsheng Hua; Weiqing Qian; Xiaoxia Wu; Lili Zhou; Lei Yu; Suning Chen; Jian Zhang; Huiying Qiu;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [J] . Jingsheng Hua, Weiqing Qian, Xiaoxia Wu, OncoTargets and therapy . 2020,第2期

机译：抗CD22和抗CD19嵌合抗原受体T细胞的顺序输注用于儿科pH样的B-所有患者在卡特 - 细胞和HAPLO-HSCT疗法后复发的患者：案例报告和文学审查
2. Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review [J] . Journal of Cancer Research and Clinical Oncology . 2020,第6期

机译：用复发的难治性Burkitt淋巴瘤的儿童序贯抗CD19,22和20个自体嵌合抗原受体T细胞（Car-T）治疗：案例报告和文献综述
3. Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review (vol 146, pg 1575, 2020) [J] . Journal of Cancer Research and Clinical Oncology . 2020,第8期

机译：与复发难治性Burkitt淋巴瘤的儿童的顺序抗CD19,22和20个自体嵌合抗原受体T细胞（Car-T）治疗：一个案例报告和文献综述（Vol 146，PG 1575,2020）
4. Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature Corrigendum [O] . 2020

机译：CART-细胞和Haplo-HSCT治疗后复发的小儿Ph-like B-ALL患者抗CD22和抗CD19嵌合抗原受体T细胞的顺序输注：病例报告和文献复习更正
5. An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells [O] . Yajing Zhang, Wenying Zhang, Hanren Dai, 2016

机译：分析性生物标志物治疗输注抗CD19嵌合抗原受体T（CAR-T）细胞诱导的缓解后复发性B-ALL的患者

>Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature Corrigendum

著录项

引文网络

相似文献

相关主题

期刊订阅